Results 371 to 380 of about 256,813 (405)
Some of the next articles are maybe not open access.
Allogeneic hematopoietic stem cell transplantation
Current Opinion in Organ Transplantation, 2001H. Bertz
openaire +3 more sources
Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma [PDF]
Clinical Lymphoma, 2004 For patients with relapsed or refractory Hodgkin's or non-Hodgkin's lymphomas, allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option when autologous HSCT fails to achieve durable remission or is deemed inappropriate. Allogeneic HSCT can result in long-term survival even in patients with refractory lymphomas.
Michael R. Bishop, Robert M. Dean
openaire +2 more sources
Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Cancer Investigation, 2014Infection, graft-versus-host disease (GVHD), and to a lesser extent sinusoidal obstructive syndrome (SOS) represent the major causes of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). During the last decade, progress in prevention and treatment of these complications led to improvement in the ...
El-Amm, Joelle +5 more
openaire +4 more sources
Nonablative allogeneic hematopoietic stem cell transplantation
Current Opinion in Oncology, 2001During the past few years there has been an explosion of knowledge in nonablative allogeneic stem cell transplantation. This approach to transplantation relies more on the creation of "immunologic space" for engraftment rather than the more traditional approach of creating "physical space" by the application of either intensive radiation or chemical ...
Roger Dansey, Roy D. Baynes
openaire +3 more sources
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
Current Opinion in Hematology, 2006This review summarizes the current status and new developments in allogeneic hemopoietic stem cell transplantation strategies for patients with myelofibrosis with myeloid metaplasia, focusing on novel concepts of allogeneic transplantation with reduced-intensity conditioning.No substantial progress has been made in the conventional management of ...
Andrea Bacigalupo, Giovanni Barosi
openaire +3 more sources
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Journal of Clinical Oncology, 2019PURPOSE Clonal hematopoiesis of indeterminate potential (CHIP) occurs in the blood of approximately 20% of older persons. CHIP is linked to an increased risk of hematologic malignancies and of all-cause mortality; thus, the eligibility of stem-cell ...
Mareike Frick +37 more
semanticscholar +1 more source
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
Blood, 2003Abstract Fifty-six patients, 10 to 66 years of age, with idiopathic myelofibrosis (IMF) or end-stage polycythemia vera or essential thrombocythemia received allogeneic hematopoietic cell transplants from related (n = 36) or unrelated (n = 20) donors.
T. Gooley +36 more
openaire +3 more sources
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
Annual Review of Immunology, 2007Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host.
Lisbeth A. Welniak +2 more
openaire +3 more sources